Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.

Background: We have been studying the native humoral immune response to cancer and have isolated a library of fully human autoantibodies to a variety of malignancies. We previously described the isolation and characterization of two fully human monoclonal antibodies, 27.F7 and 27.